|
Volumn 383, Issue 9911, 2014, Pages 2-
|
Type 1 diabetes - Progress and prospects
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GLUCOSE;
HEMOGLOBIN A1C;
INSULIN;
TEPLIZUMAB;
CARDIOVASCULAR DISEASE;
CELL FUNCTION;
DIABETIC NEPHROPATHY;
DIABETIC NEUROPATHY;
DIABETIC RETINOPATHY;
EDITORIAL;
FOLLOW UP;
GLYCEMIC CONTROL;
HUMAN;
IMMUNOLOGICAL TOLERANCE;
INSULIN DEPENDENT DIABETES MELLITUS;
LONG TERM CARE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OUTCOME ASSESSMENT;
PANCREAS ISLET TRANSPLANTATION;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
SECONDARY PREVENTION;
STEM CELL TRANSPLANTATION;
BLOOD GLUCOSE MONITORING;
DISEASE COURSE;
PANCREAS ISLET BETA CELL;
BLOOD;
GLUCOSE BLOOD LEVEL;
METABOLISM;
BLOOD GLUCOSE;
DIABETES MELLITUS, TYPE 1;
HUMANS;
|
EID: 85047053760
PISSN: 01406736
EISSN: 1474547X
Source Type: Journal
DOI: 10.1016/S0140-6736(13)62715-4 Document Type: Editorial |
Times cited : (4)
|
References (0)
|